Format

Send to

Choose Destination
Blood. 2019 May 23;133(21):2348-2351. doi: 10.1182/blood-2019-01-897637. Epub 2019 Feb 22.

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy.

Author information

1
Department of Leukemia.
2
Department of Lymphoma, and.
3
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center